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This study aimed to assess the role of H2S in homocysteine-induced cardiodynamic effects in the isolated rat
heart. The hearts were retrogradely perfused according to the Langendorff technique. The maximum and
minimum rates of pressure in the left ventricle (dp/dt max, dp/dt min), systolic and diastolic left ventricular
pressures (SLVP, DLVP), heart rate (HR), and coronary ﬂow (CF) were measured. A spectrophotometrical
method was used to measure the following oxidative stress markers: index of lipid peroxidation (thiobarbituric
acid reactive substances, TBARS), nitrite level (NO2
−), superoxide anion radicals (O2•
−), and hydrogen peroxide
(H2O2) concentrations. The administration of 10 μmol/l DL-homocysteine (DL-Hcy) alone decreased dp/dt
max, SLVP, and CF but did not change any oxidative stress parameters. The administration of 10 μmol/l
DL-propargylglycine (DL-PAG) decreased all cardiodynamic parameters and increased the concentration of O2•
−.
The co-administration of DL-Hcy and DL-PAG induced a signiﬁcant decrease in all estimated cardiodynamic
parameters and decreased the concentration of NO2
− and O2•
− but increased the levels of TBARS and H2O2.
Homocysteine shows a lower pro-oxidative effect in the presence of hydrogen sulﬁde (H2S), which indicates a
potential anti-oxidative capacity of H2S.
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Introduction
Homocysteine (Hcy) is a sulfur-containing amino acid whose elevated values have a high
correlation with the increased risk for cardiovascular diseases (CVDs). For this reason,
hyperhomocysteinemia (HHcy) is suggested as a new and independent risk factor for
developing these conditions (38, 39). HHcy occurs as a consequence of an impaired re-
methylation process or a deﬁciency in Hcy metabolic enzymes [cystathionine β-synthase
(CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfur transferase] (19). These
three enzymes break down Hcy into hydrogen sulﬁde (H2S) (33). Together with nitric oxide
(•NO), carbon monoxide (CO), and methane, H2S belongs to a group of gaseous messengers
whose importance in different pathophysiological processes has rapidly increased over the
years (11, 23, 24, 30, 34).
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In the cardiovascular system (CVS; the heart and aorta), H2S is generated by CSE (45)
and manifests effects opposite to those of Hcy (28). H2S acts as a vasorelaxant (45) and an
inhibitor of hypertrophy and ﬁbrosis of vascular smooth muscle cells (17). Taking into
consideration that HHcy can be caused by the inhibition of metabolic enzymes that produce
H2S from Hcy (19), the question arises whether the blockade of H2S synthesis inﬂuence
homocysteine-induced cardiac effects.
It is considered that hyperhomocysteinemia has adverse effects on the endothelium of
blood vessels, mainly by increasing the production of free radicals, superoxide anion radicals
(O2
•−), and hydrogen peroxide (H2O2) (16, 22, 36, 39). The connection between the
metabolism of homocysteine, free radicals, and H2S in the CVS is still insufﬁciently
investigated (31). However, much research has proven that H2S is able to directly scavenge
reactive oxygen species (ROS) and downregulate the ROS-producing enzymes, which
indicates that H2S is a potent vasodilator and has powerful anti-inﬂammatory, antioxidant,
and antiapoptotic effects (2, 20, 21, 41–43, 45).
To reveal the mechanisms by which homocysteine inﬂuences myocardium and coronary
circulation, we aimed to investigate the role of H2S and oxidative stress in these effects of
homocysteine.
Materials and Methods
Eight-week-old male Wistar albino rats with a body mass of 250± 30 g were kept in standard
laboratory conditions (air temperature 23± 10 °C, relative humidity 50%), 12:12 dark–light
cycle (the beginning of the light period was at 9 a.m.) and given water and food ad libitum.
All research procedures were carried out in accordance with European Directive for welfare
of laboratory animals (No. 86/609/EEC) and principles of good laboratory practice, approved
by ethical committee of the Faculty of Medical Sciences (Reg. No. 01-994/4), University of
Kragujevac, Serbia. The rats were divided into three experimental groups (12 animals per
group). The hearts of the rats were excised and perfused according to the modiﬁed
Langendorff technique at constant pressure conditions (Experimetria Ltd., Budapest,
Hungary) as described previously (48). The animals were premedicated with heparin as an
anticoagulant, and brieﬂy, under ether anaesthesia, were sacriﬁced by cervical dislocation
(Schedule 1 of the Animals/Scientiﬁc Procedures, Act 1986, UK). After emergency
thoracotomy and rapid cardiac arrest by superfusion with ice-cold isotonic saline, the hearts
were rapidly excised; the aortas were cannulated and retrogradely perfused at the constant
pressure of 70 cm H2O. The composition of the non-recirculating Krebs–Henseleit perfusate
was as follows (in mmol/l): NaCl 118, KCI 4.7, CaCl2 × 2H2O 2.5, MgSO4 × 7H2O 1.7,
NaHCO3 25, KH2PO4 1.2, glucose 11, and pyruvate 2, equilibrated with 95% O2 + 5% CO2
and warmed to 37 °C (pH 7.4). Immediately after the normal heart rhythm returned, the
sensor (transducer BS4 73-0184, Experimetria Ltd., Budapest, Hungary) was inserted
through the newly damaged left atrium and mitral valve into the left ventricle for continuous
monitoring of cardiac function.
To test coronary vascular reactivity, all hearts were challenged by short-term occlusions
(5–30 s) followed by a bolus injection of 5 mmol/l adenosine [60 μl at a ﬂow rate of
10 ml/min to elicit maximum coronary ﬂow (CF)] during the stabilization period. Hearts were
discarded if the ﬂow did not increase by 100% over the control value for both tests
(approximately 25% of the hearts). CF was measured using ﬂowmetry. When the ﬂow was
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considered stable (three measurements with the same value), coronary efﬂuent samples were
collected.
After perfusion in the absence of any substance (control conditions), the hearts were
perfused as follows:
Group 1: 10 μmol/l DL-homocysteine (DL-Hcy)
Group 2: 10 μmol/l DL-propargylglycine (DL-PAG) – irreversible CSE inhibitor
Group 3: 10 μmol/l DL-Hcy + 10 μmol/l DL-PAG
Groups were chosen to separate the independent inﬂuence of homocysteine (Group 1) or
the endogenous CSE/H2S pathway (Group 2) and to estimate the role of H2S in the cardiac
effects of homocysteine (Group 3). Each of the applied substances was perfused for a
duration of 5 min. The substances were ﬁrst dissolved in Krebs–Henseleit solution and, after
control conditions, applied directly to the heart by perfusion pump.
By placing the sensor in the left ventricle, the following parameters of myocardial
function were continuously registered:
(1) Maximum rate of pressure development in the left ventricle (dp/dt max);
(2) Minimum rate of pressure development in the left ventricle (dp/dt min);
(3) Systolic left ventricular pressure (SLVP);
(4) Diastolic left ventricular pressure (DLVP);
(5) Heart rate (HR).
CF was measured using the ﬂowmetric method and expressed in ml/min.
Coronary venous efﬂuent (5 ml) was collected at the same time, at the end of control
conditions and during the last minute of perfusion with any of the test compounds. Oxidative
stress parameters [the index of lipid peroxidation (thiobarbituric acid reactive substances,
TBARS), the superoxide anion radical (O2
•−), H2O2, and nitrite (NO2
−)] were determined in
coronary venous efﬂuent samples using the spectrophotometric method (Specord S-600
Analytik Jena).
Table II. The levels of pro-oxidants in coronary venous efﬂuent
O2•
− (nmol/ml) H2O2 (nmol/ml) NO2
− (nmol/ml) TBARS (μmol/ml)
(a) Before and after the application of DL-homocysteine
Control (mean± SE) 3.84± 0.83 0.48± 0.05 1.43± 0.24 0.75± 0.17
DL-Hcy (mean± SE) 5.21± 3.84 0.45± 0.02 1.40± 0.20 0.86± 0.21
(b) Before and after the application of DL-propargylglycine
Control (mean± SE) 25.35± 0.86 35.76± 0.52 2.80± 0.41 23.46± 1.26
DL-PAG (mean± SE) 26.30± 1.05* 34.95± 1.05 2.77± 0.36 24.82± 1.00
(c) Before and after the co-application of DL-Hcy and DL-PAG
Control (mean± SE) 81.46± 1.85 6.47± 0.45 18.11± 0.85 6.25± 0.83
DL-Hcy+DL-PAG
(mean± SE)
63.36± 1.89* 8.02± 0.49* 15.43± 0.74* 12.01± 0.96*
The values are expressed as the mean± SE.
*Statistical signiﬁcance (p< 0.05)
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Determination of the index of lipid peroxidation (TBARS)
The degree of lipid peroxidation in the coronary venous efﬂuent was estimated by measuring
TBARS using 1% thiobarbituric acid in 0.05 NaOH incubated with the coronary efﬂuent at
100 °C for 15min and read at 530 nm.Krebs–Henseleit solutionwas used as a blank probe (27).
Determination of superoxide anion radical (O2
•−)
The level of the superoxide anion radical (O2
•−) was measured by nitro blue tetrazolium
reaction in Tris-buffer with coronary venous efﬂuent and read at 530 nm. Krebs–Henseleit
solution was used as a blank probe (4).
Determination of hydrogen peroxide (H2O2)
The measurement of H2O2 was based on the oxidation of phenol red by H2O2 in a reaction
catalyzed by horseradish peroxidase (HRPO) (29). The volume of 200 μl of perfusate
was precipitated with 800 μl of fresh phenol red solution along with 10 μl 1:20 HRPO (made
ex tempore). An adequate volume of Krebs–Henseleit solution was used for a blank probe
(instead of coronary venous efﬂuent). The level of H2O2 was measured at 610 nm.
Determination of the nitrite level (NO2
−)
The nitrite level (NO2
−) was measured as an index of •NO production using the Griess reagent.
A total of 0.5 ml of perfusate was precipitated with 200 μl of 30% sulfosalicylic acid, vortexed
for 30 min, and centrifuged at 3,000× g. Equal volumes of the supernatant and Griess reagent,
containing 1% sulfanilamide in 5% phosphoric acid, 0.1% naphthalene ethylenediamine
dihydrochloride were added, incubated for 10 min in the dark, and read at 543 nm. The
nitrite levels were calculated using sodium nitrite as the standard (15).
All drugs were purchased from Sigma-Aldrich Chemie GmbH, Germany.
Statistical data processing
Statistical processes have been performed using the SPSS Statistics 19 program (IBM Corp.,
Armonk, USA). Variables are presented as mean values± standard deviation. We used non-
parametric methods (Wilcoxon test) to calculate the signiﬁcance of the differences between
the data. A value of p< 0.05 is considered statistically signiﬁcant. After statistical processing
of the data, the results were shown in tables.
Results
The effects of DL-Hcy, DL-PAG, and DL-Hcy +DL-PAG on myocardial function parameters
in the isolated rat heart
The administration of DL-Hcy on an isolated rat heart induced a signiﬁcant decrease of the
dp/dt max, SLVP and CF, compared to control conditions (Table Ia).
The administration of DL-PAG induced a signiﬁcant decrease of all the estimated
cardiodynamic parameters (Table Ib).
The effects of DL-Hcy and DL-PAG co-administration also induced a signiﬁcant
decrease of all the estimated cardiodynamic parameters (Table Ic).
The effects of DL-Hcy, DL-PAG, DL-Hcy + DL-PAG on oxidative stress markers in the
isolated rat heart
Perfusion with DL-Hcy showed that there were no signiﬁcant changes in the levels of all the
estimated oxidative stress parameters in the coronary venous efﬂuent (Table IIa).
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The administration of DL-PAG induced a signiﬁcant increase in the levels of O2
•− in the
coronary venous efﬂuent, whereas other parameters of oxidative stress showed no statistically
signiﬁcant differences (Table IIb).
The effects of DL-Hcy and DL-PAG co-administration on oxidative stress parameters
induced a signiﬁcant decrease in the levels of NO2 and O2
•−, and a signiﬁcant increase in
TBARS and H2O2 (Table IIc).
Discussion
One of the objectives of this study was to examine the direct effects of the basic form of
homocysteine on the myocardium and the coronary circulation in the isolated rat heart.
Although it has been well known that homocysteine has an increasingly signiﬁcant role in the
pathophysiology of CVDs (1, 12), the majority of investigations examined the inﬂuence of
homocysteine on the vascular system (3, 25), while the effects on the myocardium and the
coronary circulation are little known.
The results obtained show that homocysteine leads to a signiﬁcant reduction of the
following major cardiodynamic parameters: dp/dt max and SLVP, and also CF (Table Ia).
Related to our research, and with respect to the similarity with our experimental
model, Kennedy et al. (18) studied the acute effects of homocysteine (30–100 μmol) on
systolic function and contractibility of myocardium; they found similar results in that
there was a signiﬁcant reduction of systolic function and contractive abilities (dp/dt max)
in the isolated rat heart, but no changes in diastolic function were recorded, regardless of
the applied dose.
Wan et al. (40) examined the effects of homocysteine in a cardiac ischemia model. The
study showed that homocysteine reduced the contractible ability (dp/dt max), but without the
effect on SLVP, DLVP and HR, which was very similar to our ﬁndings. Although our
research was performed on healthy hearts, it is obvious that homocysteine in both normoxic
and hypoxic conditions, either acutely or chronically administered, has a direct negative
effect on cardiac function. One of the potential explanations for such results may be the fact
that DL-Hcy, via still unknown mechanisms, showed cardiotoxic effects on cultured isolated
cardiomyocytes (35).
On the other hand, it has been documented that gasotransmitters (•NO, CO, and H2S) are
increasingly important in various pathophysiological states in the heart. Using the same
Langendorff apparatus, Bak et al. (5–7) have shown that CO could be a powerful tool for
functional recovery of post-ischemic rat or mouse heart. H2S is a biologically active gas
whose role in the effects of homocysteine on the heart was investigated. In the conditions
when there is enough methionine and homocysteine, homocysteine is subject to the process
of transsulfuration when it converts into cystathionine with the help of the enzyme CBS in the
presence of serine. Then, under the inﬂuence of the other enzyme CSE, cystathionine
metabolizes to L-cysteine to ﬁnally generate H2S, α-keto barbiturates and ammonium (32). It
implies that this signal molecule may have an inﬂuence on the effects of homocysteine on
the CVS.
The effects of endogenous and exogenous H2S on the CVS have been intensively
investigated, but the data obtained are still incoherent and without precise conclusions (32,
46). Much less is known about the effects of H2S on the myocardium and the coronary
circulation. We decided to inhibit the enzyme CSE, which is supposed to be an endogenous
source of H2S in the heart (13), by the administration of DL-PAG. The administration of
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DL-PAG leads to a considerable reduction of all the examined cardiodynamic parameters,
although the function and perfusion of the myocardium were weakened (Table Ib).
In comparison to our study, Carson et al. (9) studied the effects of H2S on the
myocardium and coronary perfusion in the same experimental model (Langendorff retro-
grade perfusion). This group showed that exogenously administered H2S induced a dose-
dependent reduction of dp/dt max and min like in the HR of the isolated rat heart, while
paradoxically increasing the CF. In comparison to our study, these results could be due to
different experimental approaches (exogenous uptake).
Although they are still unclear, the mechanisms by which H2S inﬂuences the heart and
coronary circulation probably include activation of KATP channels in both cardiomyocytes
(47) and coronary smooth muscles (37). Despite the insufﬁcient knowledge of the role of H2S
in the heart functioning, the coronary circulation and the discrepancy between the existing
data, this gasotransmitter can obviously be synthesized in the heart, and together with •NO
and CO may be signiﬁcant in the pathophysiology of the heart.
In our study, the potential role of H2S in the effects of homocysteine on the myocardium
and coronary vascular tonus was examined by the combined administration of homocysteine
with a CSE inhibitor (DL-PAG). The administration of DL-PAG with DL-Hcy statistically
signiﬁcantly reduced the values of all cardiodynamic parameters (Table Ic).
In a study that used an experimental model similar to ours, the inﬂuence of H2S on the
infarction of myocardium in rats with hyperhomocysteinemia was examined (10). This
research showed that in the case of development of hyperhomocysteinemia, myocardium
expression and activity of CSE, and hence H2S, were signiﬁcantly reduced. On the other
hand, the administration of H2S during the period prior to ischemia improved functional
recovery of the heart and reduced the bulk of infarction, which showed that H2S could be
signiﬁcant in the ischemic preconditioning and reperfusion period.
The connection between homocysteine and oxidative stress has long been known. Like
all thiols, homocysteine easily enters the processes of oxidation such as self-oxidation in
plasma. During the oxidation of the sulfhydryl group, homocysteine generation of various
ROS occurs, above all O2
•−, H2O2, and OH
•−. These ROS then initiate lipid peroxidation of
vascular endothelial cells and their morphofunctional disorder. The O2
•− interacts with •NO
produced by the same cells, thereby generating even more toxic reactive nitrogen species –
ONOO•−. Thus, the damage to endothelial cells impairs the control of vascular tonus and
leads to the endothelial dysfunction (16, 22, 36, 39).
One of the studies showed that homocysteine increased the production of pro-oxidation
markers (TBARS) and reduced the activity of anti-oxidation enzymes of protection in the rat
heart (26). The results of our study indicate that after the application of the basic
homocysteine form (Table IIa), there were no signiﬁcant changes in the values of all
examined oxidative stress markers. In our case, the effects of acutely administered homo-
cysteine were examined, whereas the previous research treated chronic effects. In addition,
the dose of homocysteine in the present study was incomparably smaller to lead to possible
damage. Additionally, it should be noted that our model was based on physiological
conditions of cardiac function.
We wanted to examine a potential role of H2S in the stimulation of oxidative stress. The
majority of available data show that H2S often reduces the production of ROS, i.e., it has an
anti-oxidative character in the CVS (2, 20, 21, 41–43, 45). In our study, the administration of
the inhibitor CSE/H2S system (DL-PAG) induced the increased release of superoxide anion
radicals in coronary venous efﬂuent, while the levels of other parameters in the oxidative
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stress did not show statistically signiﬁcant change in comparison to the control conditions
(Table IIb).
Our results are in accordance with those of Gao et al. (14), who examined the inﬂuence
of exogenous (NaHS) and endogenous H2S (DL-PAG) on the development of oxidative
stress during ischemia and reperfusion of myocardium. They showed that the H2S donor,
NaSH,was related to the reduced lipid peroxidation,ROSproduction, and consequent decrease
of the size of infarction. On the other hand, the blockage of synthesis of endogenous H2S
induced opposite effects. These ﬁndings show that H2S could have a cardioprotective effect.
Based on these results, we can assume that H2S, either exogenous or endogenous, seems
to possess a certain anti-oxidative capacity that should be conﬁrmed in further studies.
Additionally, future research should be extended to use a wider range of administered doses
to determine possible dose-dependence of the obtained effects.
It remains little known how signiﬁcant H2S is in the oxidative effects in the presence of
homocysteine. According to the latest data, H2S can reduce the endothelial stress induced by
homocysteine (8, 10). Namely, endothelial cells are capable of secreting CBS and CSE
enzymes, which then, while circulating, actively generate H2S from homocysteine (8). In the
presence of homocysteine, the H2S synthesized in this way prevents oxidative damage and
consequent dysfunction of endothelial cells (8, 10, 44).
Yan et al. (44) examined whether H2S could inﬂuence the cytotoxicity and oxidative
stress induced by homocysteine. Cultures of smooth aortic muscles were exposed to
homocysteine in the presence or absence of an H2S donor (NaHS) in increasing doses.
The study showed that homocysteine in combination with small concentrations of H2S
reduced the production of H2O2, ONOO
•− and O2
•−, and cell damage. The results of our
study show that after the co-administration of DL-Hcy and DL-PAG, the levels of NO2
− and
O2
•− statistically signiﬁcantly decreased, while TBARS and H2O2 increased (Table IIc), so
we cannot ﬁnd a dominant trend in the dynamics of these parameters. In the case of the basic
forms of homocysteine, H2S does not yet have a precise pro- or anti-oxidative potential.
However, in contrast to other studies (44), we examined the effects of endogenous H2S.
Conclusion
The acute and direct effects of homocysteine on the isolated rat heart imply negative inotropic
and lusitropic effects and a vasoconstrictor inﬂuence on the coronary endothelium. The
inhibition of H2S synthesis led to complete depression of cardiodynamics, which showed that
these gasotransmitters can play a role in the contraction of cardiomyocytes and the control of
coronary vascular tonus. Homocysteine and H2S did not contribute to the development of
oxidative stress in this study, which means that acute cardiodynamic effects are possibly not
mediated by oxidative damage. It also seems that H2S has certain anti-oxidative capacities,
which should be deﬁnitely conﬁrmed in further studies. It seems that homocysteine shows a
lower pro-oxidative effect in the presence of H2S in comparison to the absence of production
of this signal molecule, which indicates a potential anti-oxidative capacity of the mentioned
gasotransmitter.
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